Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 6—June 2011

CME ACTIVITY

Cefepime-Resistant Pseudomonas aeruginosa

Ehimare Akhabue, Marie Synnestvedt, Mark G. Weiner, Warren B. Bilker, and Ebbing LautenbachComments to Author 
Author affiliations: Author affiliation: University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Main Article

Table 4

Multivariable model of cefepime-resistant Pseudomonas aeruginosa infection and death (blood isolates only), Philadelphia, PA, USA, 2001–2006*

Variable Adjusted OR (95% CI) p value
Cefepimeiresistant organism 15.55 (3.10–77.89) 0.001
Patient in ICU at time of culture 3.22 (1.50–6.91) 0.003
APR-DRG 4.48 (1.60–12.60) 0.004
Patient transfer from outside hospital 1.26 (0.56–2.86) 0.57
Length of hospital stay before culture 1.01 (0.99–1.04) 0.80

*OR, odds ratio; CI, confidence interval; ICU, intensive care unit; APR-DRG, all-patient refined-diagnosis–related group.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO